Clinical Trials in Czechia — Country Dashboard | 1,510 EU Studies

Filter these 1,510 trials by condition, phase, sponsor and more.

Open in Search →

1,510 Registered trials

549 Recruiting

863 Completed trials

466 Sponsors active

568 Research sites

Phase III

Phase II

Phase III: 879 Phase II/III: 76 Phase II: 349 Phase I/II: 33 Phase III/IV: 13 Phase IV: 38 Phase I: 16 Phase I (Other): 40 Phase I (FiH): 14 Other: 52

Oversight events in trials active here:

67 serious breaches 465 temporary halts 21 urgent safety measures 48 unexpected events 73 corrective measures across 203 trials

View oversight register →

Top conditions

Non-small cell lung cancer 21 Crohn's disease 18 Prostate cancer metastatic 15 Colitis ulcerative 15 Pulmonary arterial hypertension 15 Asthma 14 Ovarian cancer 13 Systemic lupus erythematosus 12 Obesity 12 Multiple sclerosis 12 Dermatitis atopic 12 Diffuse large B-cell lymphoma 11

Top sponsors

Novartis Pharma AG 86 Merck Sharp & Dohme LLC 66 Janssen - Cilag International 58 Sanofi-Aventis Recherche & Developpement 53 AstraZeneca AB 50 AbbVie Deutschland GmbH & Co. KG 45 Pfizer Inc. 42 F. Hoffmann-La Roche AG 35 Bristol-Myers Squibb Services Unlimited Company 29 Amgen Inc. 27 Boehringer Ingelheim International GmbH 27 Eli Lilly & Co. 25

Cities with most trials

All 183 cities →

All trials — page 2

1,510 total

A clinical study on SHR3680 combined with androgen deprived therapy (ADT) versus Bicalutamide combined with ADT in treatment of prostate can… Pending

2024-515194-10-00 Phase III Metastatic hormone-sensitive prostate cancer with high tumor… Jiangsu Hengrui Pharmaceuticals Co. Ltd.
A Long-Term Extension Study to Evaluate the Safety and Efficacy of Ritlecitinib in Participants With Severe AA Who Have Completed Studies B7… Pending

2024-515439-31-00 Phase III Alopecia areata Pfizer Inc.
Catheter-directed thrombolysis in intermediate-high risk acute pulmonary embolism Pending

2024-516144-25-00 Phase IV intermediate-high risk acute pulmonary embolism Fakultni Nemocnice Kralovske Vinohrady
A PRECISION MEDICINE RANDOMIZED TRIAL FOR PATIENTS WITH RELAPSED OR REFRACTORY T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA BASED ON A FUNCTIONAL APP… Pending

2024-516570-30-00 Phase II Relapsed/refractory T-cell Acute Lymphoblastic Leukemia Centre Hospitalier De Versailles
Phase III Long-term Extension Trial to Assess Safety and Efficacy of CYB003 in MDD (EXTEND) Pending

2024-516805-22-00 Phase III Major Depressive Disorder Cybin IRL Limited
A clinical trial to assess the safety of EXV-802 and EXV-801 and how well they work to reduce agitation symptoms in people with Alzheimer's … Pending

2024-517388-22-00 Phase II/III Agitation in Alzheimer's Disease Dementia Exciva GmbH
A phase 2 study of ianalumab in adults with primary Immune Thrombocytopenia (ITP) and Warm-antibody Autoimmune Hemolytic Anemia (wAIHA) who … Pending

2024-518231-11-00 Phase II Immune thrombocytopenia (ITP) Warm autoimmune hemolytic ane… Novartis Pharma AG
Clinical Trial to Demonstrate the Safety and Efficacy of DUOFAG® Pending

2024-518307-22-01 Phase I (FiH) Surgical wound infection/dehiscence caused by S. aureus and/… MB PHARMA s.r.o.
Reducing Non-Alcoholic Steatohepatitis Pending

2024-518334-88-00 Phase IV Metabolic dysfunction-associated steatohepatitis Ustredni Vojenska Nemocnice Vojenska Fakultni Nemocnice Praha
Study to Investigate the Efficacy, Safety, and Tolerability of Intravenous Gammagard Liquid (Immune Globulin Infusion, 10%) for Primary Infe… Pending

2024-518420-80-00 Phase III Primary infection prophylaxis for secondary immunodeficiency… Takeda Development Center Americas Inc.
EdoxabaN foR IntraCranial Hemorrhage survivors with Atrial Fibrillation Pending

2024-518508-31-00 Phase IV High risk atrial fibrillation patients with previous intracr… Hamilton Health Sciences Corporation; PHRI Population Health Research Institute …
A Study to Learn About the Study Medicine Called PF-07275315 in Adults with Moderate-To-Severe Long-Term Breathing Difficulty, Known by the… Pending

2024-518587-12-00 Phase II MODERATE-TO-SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE (CO… Pfizer Inc.
Transmission of bacteria from healthy donor stool to the patients gut as first-line treatment of postantibiotic diarrhoea in the critically … Pending

2024-519024-25-00 Phase II Postantibiotic diarrhoea in critically ill patients Fakultni Nemocnice Kralovske Vinohrady
REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis. Pending

2024-519298-21-00 Phase III Cancer-Associated Thrombosis (CAT). Regeneron Pharmaceuticals Inc.
A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy with Standard-of-Care Combination Regimens … Pending

2024-519504-27-00 Phase III Relapsed Refractory Multiple Myeloma Regeneron Pharmaceuticals Inc.
A clinical trial to learn about the long-term safety of FUB523 (zigakibart) in people with immunoglobulin A (IgA) nephropathy who have compl… Pending

2024-519638-22-00 Phase III IgA nephropathy Novartis Pharma AG
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants with Moderate-to-Severe Atopic Dermatitis (ADAPTIVE) Pending

2024-520117-50-00 Phase II Atopic Dermatitis Inmagene LLC
A Study to Assess Adverse Events and How Pivekimab Sunirine Moves Through the Body of Pediatric Patients with Relapsed or Refractory Acute M… Pending

2024-520125-36-00 Phase I (Other) Relapsed or Refractory Acute Myeloid Leukemia; Acute Myeloi… AbbVie Deutschland GmbH & Co. KG
An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH). Pending

2024-520218-23-00 Phase II/III Pulmonary Arterial Hypertension Inhibikase Therapeutics Inc.
OCEAN(a)-PreEvent - Olpasiran trials of Cardiovascular Events And LipoproteiN(a) reduction to Prevent first major cardiovascular Events Pending

2025-520554-11-00 Phase III Cardiovascular Disease Amgen Inc.
A maintenance study to investigate the efficacy and safety of duvakitug in participants with moderately to severely active Crohn’s disease Pending

2025-521037-86-00 Phase III Immune system diseases Sanofi-Aventis Recherche & Developpement
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease Pending

2025-521113-13-00 Phase II/III Early Parkinson’s Disease Biohaven Therapeutics Ltd.
Extension Study of ADX-324 in Hereditary angioedema Pending

2025-521353-16-00 Phase III Hereditary Angioedema Adarx Pharmaceuticals Inc.
Phase 3 trial of VMX-C001 vs usual pharmacological care in patients taking a FXa direct oral anticoagulant who require urgent surgery with o… Pending

2025-521632-12-00 Phase III Patients on Factor Xa inhibitor treatment needing an urgent … VarmX B.V.

Showing 25–48 of 1,510 trials

← All countries